Connect with us

Bangladesh

Bangladesh and Belgium seal institutional cooperation on cancer care and research

SHARE:

Published

2 years ago

on

We use your sign-up to provide content in ways you've consented to and to improve our understanding of you. You can unsubscribe at any time.

A Memorandum of Understanding (MoU) on Cooperation in Cancer Care and Research between the between the National Institute of Cancer Research & Hospital (NICRH), Bangladesh, and Bordet Cancer Institute at Hôpital Universitaire  de Bruxelles (HUB), Belgium, was signed today in Brussels.

Bangladesh Ambassador to Belgium, Luxembourg and the European Union, Mahbub Hassan Saleh, signed the MoU on behalf of the NICRH. Mr. Francis de Drée, Deputy Chief Executive Officer, HUB, Dr. Jean-Michel Hougardy, Chief Medical Officer, HUB and Dr. Chloé Spilleboudt, Physician-in-Chief of the Bordet Institute, signed the MoU on behalf of the HUB.

The MoU aims to foster strong partnership between these two institutions for conducting joint research activities and bringing specific expertise on cancer care through capacity building and infrastructure development. This MoU will be a tool for collaboration in cancer research, including basic, epidemiologic, prevention, diagnosis, screening, treatment, cancer control and survivorship research.

Bordet Cancer Institute is an internationally reputed multidisciplinary medical institution in Belgium for more than 75 years, dedicated entirely to the fight against cancer. This institute offers patients leading-edge diagnostic and therapeutic measures in the prevention, screening and active treatment of all types of cancer. The Institute also carries out important research activities which every year leads to major discoveries, as well as providing high-level, specialized university training.

The MoU is the result of three years of discussion and negotiation between both sides, facilitated by the Bangladesh Embassy in Brussels. Sharing details of the state-of-start facilities available at the Jules Bordet Institute, Francis de Drée said he and his team are very enthusiastic to start the collaboration with Bangladesh. 

Expressing happiness at the signing of the MoU, Ambassador Mahbub Hassan Saleh said that this MoU paves the way for Bangladesh to take a significant step forward in cancer treatment and research, as the country, under the dynamic and visionary leadership of Prime Minister Sheikh Hasina, moves towards building a knowledge-based society leading to achieving her vision of a ‘Smart Bangladesh’ by 2041.  

Advertisement

Share this article:

Share this:
Related Topics:
EU Reporter publishes articles from a variety of outside sources which express a wide range of viewpoints. The positions taken in these articles are not necessarily those of EU Reporter. Please see EU Reporter’s full Terms and Conditions of publication for more information EU Reporter embraces artificial intelligence as a tool to enhance journalistic quality, efficiency, and accessibility, while maintaining strict human editorial oversight, ethical standards, and transparency in all AI-assisted content. Please see EU Reporter’s full A.I. Policy for more information.
Advertisement

Trending